skip to main content

H.R. 2113 (116th): Prescription Drug STAR Act

Call or Write Congress

To amend titles XI and XVIII of the Social Security Act to provide for drug manufacturer price transparency, to require certain manufacturers to report on product samples provided to certain health care providers, and for other purposes.

The bill’s titles are written by its sponsor.

Sponsor and status

Richard Neal

Sponsor. Representative for Massachusetts's 1st congressional district. Democrat.

Read Text »
Last Updated: Dec 24, 2020
Length: 28 pages
Introduced
Apr 8, 2019
116th Congress (2019–2021)
Status
Died in a previous Congress

This bill was introduced on April 9, 2019, in a previous session of Congress, but it did not receive a vote.

Although this bill was not enacted, its provisions could have become law by being included in another bill. It is common for legislative text to be introduced concurrently in multiple bills (called companion bills), re-introduced in subsequent sessions of Congress in new bills, or added to larger bills (sometimes called omnibus bills).

Cosponsors

11 Cosponsors (8 Democrats, 3 Republicans)

Source

Position statements

What legislators are saying

Neal Opening Statement at Markup of the Prescription Drug...
    — Rep. Richard Neal [D-MA1] (Sponsor) on Apr 9, 2019

Dr. Burgess Remarks on Drug Pricing Transparency
    — Rep. Michael Burgess [R-TX26] on May 21, 2019

Government Takeover Drug Pricing Edition
    — Rep. Adrian Smith [R-NE3] on Oct 28, 2019

More statements at ProPublica Represent...

What stakeholders are saying

R Street Institute SpendingTracker.org estimates H.R. 2113 will save $1.7 billion through 2029.

History

Apr 8, 2019
 
Introduced

Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber.

Apr 9, 2019
 
Ordered Reported

A committee has voted to issue a report to the full chamber recommending that the bill be considered further. Only about 1 in 4 bills are reported out of committee.

H.R. 2113 (116th) was a bill in the United States Congress.

A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

Bills numbers restart every two years. That means there are other bills with the number H.R. 2113. This is the one from the 116th Congress.

This bill was introduced in the 116th Congress, which met from Jan 3, 2019 to Jan 3, 2021. Legislation not passed by the end of a Congress is cleared from the books.

How to cite this information.

We recommend the following MLA-formatted citation when using the information you see here in academic work:

“H.R. 2113 — 116th Congress: Prescription Drug STAR Act.” www.GovTrack.us. 2019. September 17, 2021 <https://www.govtrack.us/congress/bills/116/hr2113>

Where is this information from?

GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.